CAUTION: Investigational devices. Limited by US law to investigational use.

Clinical Program

Investigational Devices

FAST-CTOs Study

Enrollment in FAST-CTOs - Facilitated Antegrade Steering Technique in Chronic Total Occlusions - initiated in Europe and planned for the United States

Up to 300 patients (150 US; 150 EU) presenting with a CTO refractory to conventional guidewire use - defined by one of the following:

Technical Success Defined As:
The ability of the CrossBoss™ CTO Catheter, Stingray™ CTO Orienting Balloon Catheter and/or Stingray™ Re-Entry Guidewire to successfully facilitate placement of a guidewire beyond a CTO in the vessel true lumen in cases that were otherwise refractory to treatment with a conventional guidewire.

Safety Endpoint: 30-Day MACE Rates

For more info on Clinical Study Design

Procedure Sequence

You need flash player to view this video. You can download flash player here.